| A comprehensive single cell transcriptional landscape of human hematopoietic progenitors D Pellin, M Loperfido, C Baricordi, SL Wolock, A Montepeloso, ... Nature communications 10 (1), 2395, 2019 | 292 | 2019 |
| Intracerebroventricular delivery of hematopoietic progenitors results in rapid and robust engraftment of microglia-like cells A Capotondo, R Milazzo, JM Garcia-Manteiga, E Cavalca, A Montepeloso, ... Science advances 3 (12), e1701211, 2017 | 43 | 2017 |
| Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy S Ungari, A Montepeloso, F Morena, F Cocchiarella, A Recchia, S Martino, ... Molecular Therapy-Methods & Clinical Development 2, 2015 | 35 | 2015 |
| Methods and compositions for reconstituting microglia A Biffi, A Montepeloso US Patent App. 17/632,752, 2022 | 1 | 2022 |
| An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II S Das, F Rruga, A Montepeloso, A Dimartino, S Spadini, G Corre, J Patel, ... Molecular Therapy, 2024 | | 2024 |
| Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells V Poletti, A Montepeloso, D Pellin, A Biffi Molecular Therapy-Methods & Clinical Development 31, 2023 | | 2023 |
| Targeted gene addition at the CX3CR1 locus of human HSPCs improves their ability to repopulate the myeloid CNS compartment and drives lineage specific and robust transgene … A Biffi, A Montepeloso, D Mattioli, D Pellin, M Peviani, P Genovese | | 2023 |
| Targeting CX3CR1 Gene to Improve Microglia Reconstitution and Transgene Delivery into the CNS Upon Hematopoietic Stem and Progenitor Cell Transplant A Montepeloso, D Mattioli, JF Molina-Estevez, D Pellin, P Genovese, ... MOLECULAR THERAPY 30 (4), 57-58, 2022 | | 2022 |
| CX3CR1 Haploinsufficiency Improves the Ability of Hematopoietic Stem and Progenitor Cells to Generate a Microglia-Like Progeny Upon Transplantation A Montepeloso, D Mattioli, J Molina-Estevez, D Pellin, M Belloni, ... MOLECULAR THERAPY 28 (4), 486-486, 2020 | | 2020 |
| Understanding and challenging the contribution of HSCs to brain myeloid cell turnover A Montepeloso, C Baricordi, D Pellin, R Milazzo, L Biasco, M Peviani, ... HUMAN GENE THERAPY 30 (11), A101-A102, 2019 | | 2019 |
| Improving the ability of hematopoietic stem cells to generate a microglia-like progeny upon transplantation A Montepeloso, M Belloni, JF Molina-Estevez, N Gomez-Ospina, ... HUMAN GENE THERAPY 30 (11), A95-A96, 2019 | | 2019 |
| Long term effect of Prostaglandin E2 exposure on Hematopoietic Stem/Progenitor Cells V Poletti, A Montepeloso, C Baricordi, A Biffi HUMAN GENE THERAPY 30 (11), A100-A100, 2019 | | 2019 |
| Understanding and Challenging the Contribution of HSCs to Brain Myeloid Cell Turnover A Montepeloso, C Baricordi, R Milazzo, L Biasco, M Peviani, A Biffi MOLECULAR THERAPY 26 (5), 404-405, 2018 | | 2018 |
| Strategies to Enhance and Modulate Hematopoietic Stem Cell Contribution to Brain Myeloid Cell/Microglia Turnover R Milazzo, F Ferro, A Montepeloso, E Cavalca, V Cipolla, H Yu, S Das, ... MOLECULAR THERAPY 26 (5), 398-398, 2018 | | 2018 |
| Novel Transplantation Modalities for Generating Transcriptionally Dependable New Microglia from Hematopoietic Stem and Progenitor Cells R Milazzo, A Capotondo, JM Garcia-Manteiga, E Zonari, E Cavalca, ... MOLECULAR THERAPY 25 (5), 114-114, 2017 | | 2017 |
